ProQR Therapeutics (PRQR) Capital Expenditures Growth (1y) (2014 - 2025)
ProQR Therapeutics (PRQR) Capital Expenditures Growth (1y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
ProQR Therapeutics |
7.27 Mn |
-100.30 Mn |
- |
-38.99% |
| Date | Value |
|---|
| Dec 31, 2025 |
-38.99% |
| Sep 30, 2025 |
37.10% |
| Jun 30, 2025 |
60.24% |
| Mar 31, 2025 |
70.37% |
| Dec 31, 2024 |
25.45% |
| Sep 30, 2024 |
14.89% |
| Jun 30, 2024 |
10.19% |
| Mar 31, 2024 |
-444.76% |
| Dec 31, 2023 |
57.93% |
| Sep 30, 2023 |
-48.78% |
| Jun 30, 2023 |
-29.88% |
| Mar 31, 2023 |
46.70% |
| Dec 31, 2022 |
666.42% |
| Sep 30, 2022 |
-20.19% |
| Jun 30, 2022 |
-293.62% |
| Mar 31, 2022 |
-609.47% |
| Dec 31, 2021 |
-82.95% |
| Sep 30, 2021 |
33.08% |
| Jun 30, 2021 |
83.47% |
| Mar 31, 2021 |
-17,559.24% |
